Antioxidant and anticancer activities of chamomile (Matricaria recutita L.)

The Slovak gene pool of German chamomile (Matricaria recutita L.) and comparison in its parameters

Plant habit and production of secondary metabolites in chamomile plants depend on endogenous and exogenous factors that can be divided into two groups (FRANZ 1982): a) morpho-ontogenetic variability, b) genetic variability or genetic determinateness. The activity of these factors is reflected in biomass production, flower drug production, content and composition of essential oil and some other ...

Evaluation of Antimicrobial and Antioxidant activities of Matricaria recutita, Ricinus communis and Zygophyllum coccineum Extracts

This work aimed to evaluate the antimicrobial and antioxidant activity of methanolic extract of some plant (Ricinus communis,Matricaria recutita and Zygophyllum coccineum) extracts used in herbal remedy and folk medicine in Saudi Arabia, Results indicated that, the total extract the studied plants showed activity against the tested microbes, the highest activity was observed by using Matricaria...

Doctoral Thesis Morphological and Chemical Diversity of Different Chamomile (matricaria Recutita L.) Populations of the Great Hungarian Plain

Determination of the Antioxidant Activity and Stability of Chamomile (Matricaria chamomilla L.) Extract in Sunflower Oil

Antioxidants prevent the reaction of free radicals with biomolecules and can promote the nutritional values and physiological properties of foodstuffs. There are synthetic and natural kinds of antioxidants and nowadays there is a trend to replace the natural kinds instead of the synthetic kinds. Chamomile (Matricaria chamomilla L. ) is a well known and valuable medicinal plants that is used wid...

P02.118. Oral chamomile (Matricaria recutita) extract therapy of Generalized Anxiety Disorder (GAD): trial in progress

Purpose Chamomile is a traditional herb known for its calming effects. We are conducting a long-term, randomized, placebo-substitution study of chamomile for the prevention of recurrent Generalized Anxiety Disorder (GAD) in individuals who have responded to initial, open-label chamomile therapy. We present preliminary results from the trial’s open label phase to offer initial evidence of safety...